Key result
Adjunctive statins show potential antidepressant effects alongside standard therapy, though current evidence remains conflicting.
Why the study?
The potential antidepressant effect of statins as adjunctive therapy in clinical depression remains uncertain due to conflicting evidence.
Do statins improve symptoms of depression in people with clinical depression?
Do statins improve symptoms of depression in people with clinical depression?
Current evidence is conflicting regarding the use of statins as an adjunctive therapy for clinical depression, highlighting the need for further research.
Hypothesis-generating for statins in depression; leaves open any clinical role pending randomized trials.
Depression is a common malady associated with numerous chronic medical conditions such as coronary artery disease, hypertension, and diabetes. Statins provide protection against coronary and cerebrovascular diseases by decreasing cholesterol synthesis in the liver. Statin medications also reduce inflammation. Since the pathophysiology of depression involves inflammation, statins could have a role in the treatment of mood disorders and might become a pharmacotherapy option for patients experiencing depression. There is evidence suggesting an antidepressant effect when statins are adjunctively co-prescribed with antidepressant medicines. However, confounding data also exist refuting a positive effect of these drugs at elevating mood. More research is required to confirm a potentially beneficial effect of prescribing statins to people with clinical depression.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2018) conducted a review in Depression. Statins was evaluated. Statins may have a potential antidepressant effect when co-prescribed with antidepressant medicines, although conflicting data exist and further research is required.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: